| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |